Kymera Therapeutics, Inc. (KYMR) Corporate Subsidiaries
Kymera Therapeutics, Inc. (KYMR) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: KYMR
CIK: 1815442
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerBrendan Mc Corry
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-01 | 2026-10-01 | 4 | 0001193125-26-410839 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001969223-26-001047 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-09-08 | — | SCHEDULE 13G/A Filing | 0000080255-26-000601 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-04 | 4 | 0001193125-26-383874 | View SEC Doc Filr Page |
| 144 | 2026-09-04 | — | 144 Filing | 0001193125-26-383667 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001950047-26-009024 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000080255-26-000572 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001628098-26-000009 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001193125-26-333849 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001193125-26-333834 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-07-27 | 4 | 0001193125-26-318408 | View SEC Doc Filr Page |
| 3 | 2026-07-27 | 2026-07-27 | 3 | 0001193125-26-318404 | View SEC Doc Filr Page |
| 8-K | 2026-07-27 | 2026-07-27 | 8-K | 0001193125-26-318078 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-07 | 4 | 0001193125-26-297817 | View SEC Doc Filr Page |
| 144 | 2026-07-07 | — | 144 Filing | 0001969223-26-000769 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 | 0001193125-26-295090 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | 4 | 0001193125-26-295089 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | 4 | 0001193125-26-295088 | View SEC Doc Filr Page |
| 4/A | 2026-07-02 | 2026-06-26 | 4/A Filing | 0001451612-26-000022 | View SEC Doc Filr Page |
| 144 | 2026-07-02 | — | 144 Filing | 0001969223-26-000752 | View SEC Doc Filr Page |
| 144 | 2026-07-01 | — | 144 Filing | 0001950047-26-006765 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-26 | 4 Filing | 0001451612-26-000020 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-26 | 4 Filing | 0001451612-26-000018 | View SEC Doc Filr Page |
| 144 | 2026-06-30 | — | 144 Filing | 0001950047-26-006647 | View SEC Doc Filr Page |
| 144 | 2026-06-29 | — | 144 Filing | 0001628280-26-046098 | View SEC Doc Filr Page |